Pathological Evaluation of Sentinel Lymph Nodes

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The sentinel lymph nodes are the most likely site of nodal metastasis. Their focused analysis results in upstaging cancers, although the extra yield from a more intensive work-up is generally dominated by micrometastases and isolated tumor cells. Nodal staging is generally done to reflect systemic spread of solid tumors and guide treatment accordingly. However, in general, the two processes of haematogenous and lymphogenic spread are not causally interrelated, and the extrapolation from low-volume nodal involvement to systemic involvement and therapeutic consequences of this extrapolation are still under investigation.

Original languageEnglish
Pages (from-to)17-34
Number of pages18
JournalSurgical Oncology Clinics of North America
Volume16
Issue number1
DOIs
Publication statusPublished - Jan 2007

Fingerprint

Neoplasms
Neoplasm Micrometastasis
Neoplasm Metastasis
Sentinel Lymph Node
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Pathological Evaluation of Sentinel Lymph Nodes. / Cserni, G.

In: Surgical Oncology Clinics of North America, Vol. 16, No. 1, 01.2007, p. 17-34.

Research output: Contribution to journalArticle

@article{233703c053024dbeb56edcb9b2868a2e,
title = "Pathological Evaluation of Sentinel Lymph Nodes",
abstract = "The sentinel lymph nodes are the most likely site of nodal metastasis. Their focused analysis results in upstaging cancers, although the extra yield from a more intensive work-up is generally dominated by micrometastases and isolated tumor cells. Nodal staging is generally done to reflect systemic spread of solid tumors and guide treatment accordingly. However, in general, the two processes of haematogenous and lymphogenic spread are not causally interrelated, and the extrapolation from low-volume nodal involvement to systemic involvement and therapeutic consequences of this extrapolation are still under investigation.",
author = "G. Cserni",
year = "2007",
month = "1",
doi = "10.1016/j.soc.2006.10.002",
language = "English",
volume = "16",
pages = "17--34",
journal = "Surgical Oncology Clinics of North America",
issn = "1055-3207",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Pathological Evaluation of Sentinel Lymph Nodes

AU - Cserni, G.

PY - 2007/1

Y1 - 2007/1

N2 - The sentinel lymph nodes are the most likely site of nodal metastasis. Their focused analysis results in upstaging cancers, although the extra yield from a more intensive work-up is generally dominated by micrometastases and isolated tumor cells. Nodal staging is generally done to reflect systemic spread of solid tumors and guide treatment accordingly. However, in general, the two processes of haematogenous and lymphogenic spread are not causally interrelated, and the extrapolation from low-volume nodal involvement to systemic involvement and therapeutic consequences of this extrapolation are still under investigation.

AB - The sentinel lymph nodes are the most likely site of nodal metastasis. Their focused analysis results in upstaging cancers, although the extra yield from a more intensive work-up is generally dominated by micrometastases and isolated tumor cells. Nodal staging is generally done to reflect systemic spread of solid tumors and guide treatment accordingly. However, in general, the two processes of haematogenous and lymphogenic spread are not causally interrelated, and the extrapolation from low-volume nodal involvement to systemic involvement and therapeutic consequences of this extrapolation are still under investigation.

UR - http://www.scopus.com/inward/record.url?scp=33847337398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847337398&partnerID=8YFLogxK

U2 - 10.1016/j.soc.2006.10.002

DO - 10.1016/j.soc.2006.10.002

M3 - Article

C2 - 17336234

AN - SCOPUS:33847337398

VL - 16

SP - 17

EP - 34

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

SN - 1055-3207

IS - 1

ER -